Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Sarcoma 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Pancreatic Neoplasms 5Thromboembolism 2Hemorrhage 2Venous Thrombosis 1Thrombosis 1Stomach Neoplasms 1Pulmonary Embolism 1Liver Neoplasms 1Gastrointestinal Neoplasms 1Fibrosis 1Colorectal Neoplasms 1Carcinoma, Pancreatic Ductal 1Carcinoma, Hepatocellular 1

Interventions

Tinzaparin 3Gemcitabine 3Heparin, Low-Molecular-Weight 2Enoxaparin 2Dalteparin 2130-nm albumin-bound paclitaxel 2palbociclib 1isoquercitrin 1Watchful Waiting 1Rivaroxaban 1PEGPH20 1High-Energy Shock Waves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Thromboembolism × Enoxaparin × Gastrointestinal × Clear all
NCT02444572 2021-07-29

ENOXACARE

Les Laboratoires des Médicaments Stériles

Phase 4 Completed
168 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Thromboembolism

NCT01945879 2013-09-19

Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer

CONKO-Studiengruppe

Phase 1/2 Completed
19 enrolled
Gastrointestinal

Pancreatic Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡